Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
CompletedOBSERVATIONAL
Enrollment
25
Participants
Timeline
Start Date
November 30, 2000
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Conditions
Breast Cancer
Trial Locations (1)
94305
Stanford University School of Medicine, Stanford
All Listed Sponsors
collaborator
Susan G. Komen Breast Cancer Foundation
OTHER
lead
Stanford University
OTHER
NCT00185809 - Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study | Biotech Hunter | Biotech Hunter